✦ LIBER ✦

Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin

✍ Scribed by Gary B. Calandra; Kenneth R. Brown; L.Christine Grad; Vincent I. Ahonkhai; Cynthia Wang; Mohammed A. Aziz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Tolerability of the DPP-4 I

✍ DeFronzo, R. A.; Burant, C. F.; Fleck, P.; Wilson, C.; Mekki, Q.; Pratley, R. E. 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 427 KB

PHM4 SYSTEMATIC REVIEW OF THE COSTS OF H

✍ JM Stephens; SY Liou; KT Tran; MF Botteman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Experience with the use of a first-line

✍ J Zhou; NI Paton; R Ditangco; Y-MA Chen; A Kamarulzaman; N Kumarasamy; CKC Lee; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Comparing the safety, tolerability and q

✍ Patrick Marcellin; George K. K. Lau; Stefan Zeuzem; E. Jenny Heathcote; Paul J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

The effect of linagliptin on glycaemic c

✍ D. Singh-Franco; J. McLaughlin-Middlekauff; S. Elrod; C. Harrington 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Role of definitive radiotherapy in treat

✍ Clare SL Koh; Michael J Veness 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB